Menu

Global Forest Estimate Rises 9 Percent

Dryland biomes are covered in at least 40 percent more forest than previously estimated.

May 15, 2017
Aggie Mika

WIKIMEDIA, ARTHUR MEDEIROS

          An international team of scientists uncovered 1,803,097 square miles (467 million hectares) of previously unreported forest populating Earth’s dryland biomes, boosting forest cover globally by at least 9 percent, according to a study published last week (May 11) in the journal Science. This update estimates that forest cover in drylands is 40-47 percent higher than what has previously been found. 

Jean-François Bastin, first author on the study and an ecologist with the Food and Agriculture Organization of the United Nations, told Mongabay that he and his colleagues were “surprised and stunned” at their new estimates.

In their report, the researchers demonstrated that in 2015, out of the estimated 23.67 million square miles (6,132 million hectares) of total dryland covering the earth’s surface, 4.16 million square miles were covered in forest, while another 5.12 million square miles of dryland (1,327 million hectares) boasted more than 10 percent tree cover.

Previous studies attempting to describe forests in dryland biomes were “riddled with disparities, caused by issues such as differences in satellite spatial resolution, mapping approaches and forest definitions,” according to a press release.

In their approach, the researchers used Google Earth’s satellite data and images taken at a high frequency and resolution, which allowed for a more accurate estimate.

According to a Science report, this updated estimate will enable researchers to more accurately determine how much carbon dioxide absorption the Earth’s forests can account for. 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.